|
CMIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.469800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.818600E-01 |
| Normal-vs-Stage2 |
3.097200E-01 |
| Normal-vs-Stage3 |
1.311240E-01 |
| Normal-vs-Stage4 |
6.581000E-01 |
| Stage1-vs-Stage2 |
3.084800E-01 |
| Stage1-vs-Stage3 |
1.078380E-01 |
| Stage1-vs-Stage4 |
7.369000E-01 |
| Stage2-vs-Stage3 |
7.626000E-01 |
| Stage2-vs-Stage4 |
3.389400E-01 |
| Stage3-vs-Stage4 |
2.377400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.310600E-01 |
| Normal-vs-AfricanAmerican |
4.593200E-01 |
| Normal-vs-Asian |
3.384800E-01 |
| Caucasian-vs-AfricanAmerican |
4.844200E-02 |
| Caucasian-vs-Asian |
3.223600E-01 |
| AfricanAmerican-vs-Asian |
2.709600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.494600E-01 |
| Normal-vs-Female |
1.031630E-01 |
| Male-vs-Female |
1.397960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.663800E-01 |
| Normal-vs-Extreme_Weight |
7.751000E-01 |
| Normal-vs-Obese |
2.873800E-01 |
| Normal-vs-Extreme_Obese |
8.864000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.608400E-01 |
| Normal_Weight-vs-Obese |
2.109800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.189400E-01 |
| Extreme_Weight-vs-Obese |
2.182600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.958200E-01 |
| Obese-vs-Extreme_Obese |
7.069000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.558800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.351370E-01 |
| Normal-vs-Age(61-80Yrs) |
9.260000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.959000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.635800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.760780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.235430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.020400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.756000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.567600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.167200E-01 |
| Normal-VS-Type2 PRCC |
4.554000E-01 |
| Normal-VS-KIRP CIMP |
1.082770E-01 |
| Normal-VS-Unclassified PRCC |
1.616390E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.398000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.469200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.217200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.327400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.737800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.816800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.851160E-01 |
| Normal-vs-N1 |
5.649800E-01 |
| Normal-vs-N2 |
5.921200E-01 |
| N0-vs-N1 |
4.141200E-01 |
| N0-vs-N2 |
8.460800E-01 |
| N1-vs-N2 |
8.709000E-01 |
|
|
